Francois Blanquart

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 63 publications

Interim vaccine effectiveness against influenza virus among outpatients, France, October 2025 to January 2026.

Interim vaccine effectiveness against influenza virus among outpatients, France, October 2025 to January 2026.

Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Published: January 16, 2026

Quantitative analysis of massive SARS-CoV-2 testing in the community in France in 2021-2022 reveals the associations of variant, vaccination, and age with viral dynamics in symptomatic individuals.

Quantitative analysis of massive SARS-CoV-2 testing in the community in France in 2021-2022 reveals the associations of variant, vaccination, and age with viral dynamics in symptomatic individuals.

Journal: PLoS computational biology

Published: December 01, 2025

Influenza vaccine effectiveness and genetic diversity: insights from end-of-season community surveillance, France, 2024-2025.

Influenza vaccine effectiveness and genetic diversity: insights from end-of-season community surveillance, France, 2024-2025.

Journal: Emerging microbes & infections

Published: September 16, 2025

Vaccine effectiveness dynamics against influenza and SARS-CoV-2 in community-tested patients in France 2023-2024.

Vaccine effectiveness dynamics against influenza and SARS-CoV-2 in community-tested patients in France 2023-2024.

Journal: Emerging microbes & infections

Published: March 12, 2025

Quantifying the effects of antibiotic resistance and within-host competition on strain fitness in Streptococcus pneumoniae.

Quantifying the effects of antibiotic resistance and within-host competition on strain fitness in Streptococcus pneumoniae.

Journal: PLoS biology

Published: March 10, 2025

Influenza vaccine effectiveness against detected infection in the community, France, October 2024 to February 2025.

Influenza vaccine effectiveness against detected infection in the community, France, October 2024 to February 2025.

Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Published: February 21, 2025

The genetic architecture of HIV-1 virulence.

The genetic architecture of HIV-1 virulence.

Journal: Virus evolution

Published: February 11, 2025

Residence-colonization trade-off and niche differentiation enable coexistence of Escherichia coli phylogroups in healthy humans.

Residence-colonization trade-off and niche differentiation enable coexistence of Escherichia coli phylogroups in healthy humans.

Journal: The ISME journal

Published: January 24, 2025

The evolution of antibiotic resistance in Europe, 1998-2019.

The evolution of antibiotic resistance in Europe, 1998-2019.

Journal: PLoS pathogens

Published: December 20, 2024

Persistent, Private, and Mobile Genes: A Model for Gene Dynamics in Evolving Pangenomes.

Persistent, Private, and Mobile Genes: A Model for Gene Dynamics in Evolving Pangenomes.

Journal: Molecular biology and evolution

Published: July 15, 2024

Strain phylogroup and environmental constraints shape Escherichia coli dynamics and diversity over a 20-year human gut time series.

Strain phylogroup and environmental constraints shape Escherichia coli dynamics and diversity over a 20-year human gut time series.

Journal: The ISME journal

Published: July 02, 2024

Evolution of virulence in emerging epidemics: from theory to experimental evolution and back.

Evolution of virulence in emerging epidemics: from theory to experimental evolution and back.

Journal: Virus evolution

Published: May 23, 2024

Showing 1-12 of 63

Last Updated: 09/26/2026